Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma. [electronic resource] by
- Watanabe, Takashi
- Kato, Harumi
- Kobayashi, Yukio
- Yamasaki, Satoshi
- Morita-Hoshi, Yuriko
- Yokoyama, Hiroki
- Morishima, Yasuo
- Ricker, Justin L
- Otsuki, Tetsuya
- Miyagi-Maesima, Akiko
- Matsuno, Yoshihiro
- Tobinai, Kensei
Producer: 20100330
In:
Cancer science vol. 101
Availability: No items available.
|
|
14.
|
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). [electronic resource] by
- Duvic, Madeleine
- Talpur, Rakshandra
- Ni, Xiao
- Zhang, Chunlei
- Hazarika, Parul
- Kelly, Cecilia
- Chiao, Judy H
- Reilly, John F
- Ricker, Justin L
- Richon, Victoria M
- Frankel, Stanley R
Producer: 20070220
In:
Blood vol. 109
Availability: No items available.
|
|
15.
|
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma. [electronic resource] by
- Richardson, Paul
- Mitsiades, Constantine
- Colson, Kathleen
- Reilly, Eileen
- McBride, Laura
- Chiao, Judy
- Sun, Linda
- Ricker, Justin
- Rizvi, Syed
- Oerth, Carol
- Atkins, Barbara
- Fearen, Ivy
- Anderson, Kenneth
- Siegel, David
Producer: 20080409
In:
Leukemia & lymphoma vol. 49
Availability: No items available.
|
|
16.
|
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. [electronic resource] by
- Olsen, Elise A
- Kim, Youn H
- Kuzel, Timothy M
- Pacheco, Theresa R
- Foss, Francine M
- Parker, Sareeta
- Frankel, Stanley R
- Chen, Cong
- Ricker, Justin L
- Arduino, Jean Marie
- Duvic, Madeleine
Producer: 20070822
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 25
Availability: No items available.
|
|
17.
|
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. [electronic resource] by
- Loercher, Amy
- Lee, Tin Lap
- Ricker, Justin L
- Howard, April
- Geoghegen, Joel
- Chen, Zhong
- Sunwoo, John B
- Sitcheran, Raquel
- Chuang, Eric Y
- Mitchell, James B
- Baldwin, Albert S
- Van Waes, Carter
Producer: 20041104
In:
Cancer research vol. 64
Availability: No items available.
|
|
18.
|
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer. [electronic resource] by
- Rubin, Eric H
- Agrawal, Nancy G B
- Friedman, Evan J
- Scott, Pamela
- Mazina, Kathryn E
- Sun, Linda
- Du, Lihong
- Ricker, Justin L
- Frankel, Stanley R
- Gottesdiener, Keith M
- Wagner, John A
- Iwamoto, Marian
Producer: 20071128
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 12
Availability: No items available.
|
|
19.
|
Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma. [electronic resource] by
- Duvic, Madeleine
- Olsen, Elise A
- Breneman, Debra
- Pacheco, Theresa R
- Parker, Sareeta
- Vonderheid, Eric C
- Abuav, Rachel
- Ricker, Justin L
- Rizvi, Syed
- Chen, Cong
- Boileau, Kathleen
- Gunchenko, Alexandra
- Sanz-Rodriguez, Cesar
- Geskin, Larisa J
Producer: 20100127
In:
Clinical lymphoma & myeloma vol. 9
Availability: No items available.
|
|
20.
|
Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer. [electronic resource] by
- O'Neil, Bert H
- Cainap, Calin
- Van Cutsem, Eric
- Gorbunova, Vera
- Karapetis, Christos S
- Berlin, Jordan
- Goldberg, Richard M
- Qin, Qin
- Qian, Jiang
- Ricker, Justin L
- Fischer, JuDee
- McKee, Mark D
- Carlson, Dawn M
- Kim, Tae Won
Producer: 20150518
In:
Clinical colorectal cancer vol. 13
Availability: No items available.
|